Rajasthan govt set to revive Rajasthan Drugs and Pharma

Jaipur:  The government of Rajasthan is set to revive Rajasthan Drugs and Pharmaceuticals Limited (RDPL), a Central Public Sector Undertaking (CPSU) based in the state. RDPL is jointly owned by the Central government, which holds a 51% equity stake, and the Rajasthan state government, which owns the remaining 49%.

The decision to revive RDPL was announced earlier in the budget, and the Department of Medical and Health has begun follow-up measures. As part of this effort, Neha Giri, Managing Director of Rajasthan Medical Services Corporation Limited (RMSCL), recently conducted an inspection of the RDPL.

During the inspection, Giri was accompanied by RDPL’s Special Officer and other officials of the corporation, as per UNI.

She inspected the production area, quality control, storage facilities, main building, and campus of RDPL. She was informed that RDPL is located in an industrial area with approximately 10 acres of land under its possession.

Giri inspected the machines and equipment installed at the RDPL campus and assessed their functionality. She directed the RDPL representative to provide information about the company’s building, equipment, and all liabilities. She also sought information about the pending court cases related to RDPL and gave the necessary instructions.

The MD directed that a report be prepared on the 2016 fire incident at RDPL, as well as a compilation of information about the board of directors, currently employed staff, financial provisions, and all liabilities. She also inspected the water supply, electricity supply, biomedical waste, and designated storage areas within the RDPL campus.

Related Posts

Meiji Seika to push new vaccine with SII in India

TOKYO: Meiji Seika Pharma-owned Medreich Pharma is eyeing inorganic growth and more generics supply from India, while the parent has tied up with Serum Institute of India (SII) to launch…

DGFT automates EO extension process to ease compliance for pharma exporters

Mumbai: The Directorate General of Foreign Trade (DGFT) has introduced an automated facility for granting Export Obligation (EO) extensions in Advance Authorisation and Export Promotion Capital Goods (EPCG) Authorisation cases…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Meiji Seika to push new vaccine with SII in India

Meiji Seika to push new vaccine with SII in India

DGFT automates EO extension process to ease compliance for pharma exporters

DGFT automates EO extension process to ease compliance for pharma exporters

Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark

Udan vs Udaan: Delhi court restrains pharmaceutical firm from using ‘Udaan’ mark

Three newborns die in fire at government hospital in Amravati, Maharashtra

Three newborns die in fire at government hospital in Amravati, Maharashtra

Maharashtra FDA to prioritise process audits for revised Schedule M compliance: FDA Commissioner

Maharashtra FDA to prioritise process audits for revised Schedule M compliance: FDA Commissioner

Centre bans fixed-dose combination for Common Cold in children below four

Centre bans fixed-dose combination for Common Cold in children below four